TNBC cancer has been associated to driver mutations in the Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS), and v-Raf murine sarcoma viral oncogene homolog B (BRAF) genes, promoting the synthesis of K-RAS and RAF proteins (134). This evidence concerns the gene KRAS and cancer.